If you’re a cancer survivor, you’ve likely heard mixed messages about the relationship between dairy and cancer. Some sources say it’s beneficial, while others suggest it may increase cancer risk. So, what does the research actually say?
When Jeff Kramer felt a persistent backache in February 2023, he expected it to resolve on its own. The 63-year-old endured the discomfort for months before seeking care, which led to a shocking discovery: kidney cancer.
Prostate cancer treatment has changed a lot in recent years. What one expert calls a previously “boring space” has become one of the most exciting areas in cancer care.
A recent study suggests that performing an MRI scan in the workup for an elevated prostate-specific antigen blood test (PSA) screening for prostate cancer can reduce prostate cancer diagnoses by more than half.
Over nearly 20 years, Bill Jurgens and his family got to know the Nebraska Medical Center well. Jurgens’ time in the hospital made him more appreciative of the support he had from friends and families and the financial resources he had to help him through these difficult times.
When Phil Painter learned he had stage 4 prostate cancer last year, he wasn’t sure what the future would hold. A PET/CT scan revealed he would be the perfect candidate for a new FDA-approved prostate cancer treatment called PLUVICTO. In August, he became the first Nebraska Medicine patient to receive this treatment.
After months of low testosterone levels, Steve Gustafson knew something wasn’t right. But what he did not expect were the results of his prostate-specific antigen (PSA) test that revealed an extremely high PSA level, a protein that at an elevated level, may be a sign of prostate cancer.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?